Aehr Test Systems’ (AEHR) “Market Perform” Rating Reiterated at William Blair

William Blair reaffirmed their market perform rating on shares of Aehr Test Systems (NASDAQ:AEHRFree Report) in a research note published on Monday, Marketbeat reports. William Blair also issued estimates for Aehr Test Systems’ Q3 2024 earnings at ($0.06) EPS, Q4 2024 earnings at $0.09 EPS, FY2024 earnings at $0.39 EPS, Q1 2025 earnings at $0.06 EPS, Q2 2025 earnings at $0.12 EPS, Q3 2025 earnings at $0.15 EPS, Q4 2025 earnings at $0.21 EPS and FY2025 earnings at $0.54 EPS.

Separately, StockNews.com upgraded Aehr Test Systems from a sell rating to a hold rating in a report on Friday, January 19th.

Read Our Latest Research Report on Aehr Test Systems

Aehr Test Systems Trading Down 0.5 %

Aehr Test Systems stock opened at $12.40 on Monday. The stock has a market cap of $357.74 million, a PE ratio of 17.47 and a beta of 2.01. The stock has a 50-day moving average price of $15.82 and a 200 day moving average price of $25.42. Aehr Test Systems has a 52 week low of $10.53 and a 52 week high of $54.10.

Aehr Test Systems (NASDAQ:AEHRGet Free Report) last posted its quarterly earnings data on Tuesday, January 9th. The semiconductor company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. The firm had revenue of $21.43 million during the quarter, compared to analysts’ expectations of $20.10 million. Aehr Test Systems had a return on equity of 26.97% and a net margin of 25.76%. On average, equities analysts predict that Aehr Test Systems will post 0.72 EPS for the current year.

Insider Buying and Selling at Aehr Test Systems

In other news, CEO Gayn Erickson sold 4,871 shares of Aehr Test Systems stock in a transaction dated Thursday, January 18th. The stock was sold at an average price of $17.39, for a total value of $84,706.69. Following the transaction, the chief executive officer now directly owns 427,935 shares of the company’s stock, valued at approximately $7,441,789.65. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CEO Gayn Erickson sold 4,871 shares of Aehr Test Systems stock in a transaction dated Thursday, January 18th. The stock was sold at an average price of $17.39, for a total value of $84,706.69. Following the transaction, the chief executive officer now directly owns 427,935 shares of the company’s stock, valued at approximately $7,441,789.65. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Avijit K. Ray-Chaudhuri acquired 3,000 shares of Aehr Test Systems stock in a transaction dated Friday, January 12th. The stock was purchased at an average cost of $17.87 per share, for a total transaction of $53,610.00. Following the completion of the purchase, the vice president now directly owns 9,719 shares in the company, valued at $173,678.53. The disclosure for this purchase can be found here. Insiders sold 8,738 shares of company stock worth $151,723 in the last 90 days. 11.30% of the stock is owned by company insiders.

Hedge Funds Weigh In On Aehr Test Systems

Several hedge funds and other institutional investors have recently bought and sold shares of AEHR. Charles Schwab Investment Management Inc. raised its position in shares of Aehr Test Systems by 183.8% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 200,553 shares of the semiconductor company’s stock valued at $9,165,000 after purchasing an additional 129,890 shares in the last quarter. Invesco Ltd. raised its position in shares of Aehr Test Systems by 379.1% in the 3rd quarter. Invesco Ltd. now owns 596,660 shares of the semiconductor company’s stock valued at $27,267,000 after purchasing an additional 472,113 shares in the last quarter. Trexquant Investment LP acquired a new position in shares of Aehr Test Systems in the 3rd quarter valued at approximately $472,000. Bank of New York Mellon Corp raised its position in shares of Aehr Test Systems by 96.8% in the 3rd quarter. Bank of New York Mellon Corp now owns 192,470 shares of the semiconductor company’s stock valued at $8,796,000 after purchasing an additional 94,657 shares in the last quarter. Finally, Citigroup Inc. increased its holdings in shares of Aehr Test Systems by 588.8% in the 3rd quarter. Citigroup Inc. now owns 69,618 shares of the semiconductor company’s stock valued at $3,182,000 after acquiring an additional 59,511 shares during the last quarter. 69.69% of the stock is owned by institutional investors and hedge funds.

About Aehr Test Systems

(Get Free Report)

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.

Featured Stories

Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.